Friday, 13 November 2026 Partly cloudyNew Delhi 29° New DelhiLondonNew YorkDubaiTokyo
INDEPENDENT THINKING.
SHARED UNDERSTANDING.International edition · Correspondents across India and around the world
RationalTimes●
A little less noise.
A little more perspective. Join our media house
BREAKING
VerifiedHosts sought for three future Africa Cup of Nations finals Verified"There Was A Huge Difference": Iyer Blames Pitch After India's 244-Run Loss VerifiedAmritpal Singh Granted Parole to Attend Grandmother’s Funeral, Will Return to Punjab VerifiedDENZA enters India with Z9 GT and D9 priced from Rs 90 lakh VerifiedChina approves first oral GLP-1 weight-loss pill ClimateCOP31 climate talks open in Antalya, Türkiye, on 9 November USAmericans vote in the midterm elections on 3 November TechnologyNorth Korea-linked hackers steal about $6.4 billion from Binance in the biggest crypto theft on record, analysts say WorldSpain mourns after a high-speed train ploughs into a stationary train near Toledo, killing at least 68 WorldIsrael’s election ends without a clear winner as exit polls leave both blocs short of a majority WorldSaudi Arabia intercepts Houthi missiles and drones as Egypt’s parliament backs military support PoliticsLula wins Brazil’s presidential runoff as Flávio Bolsonaro concedes
Verified · 2 outletsWorld

China approves first oral GLP-1 weight-loss pill

Headline via Medical Xpress · first report 13 Nov, 06:31 IST, latest 13 Nov, 15:50 IST

Shanghai at night, photographed from space
Representational image · Shanghai at night, photographed from space · NASA's Earth Observatory / Wikimedia Commons, CC BY 2.0

What we know

2 independent news organisations have reported this story. The first report we saw came from South China Morning Post at 13 Nov, 06:31 IST; the latest is from Medical Xpress at 13 Nov, 15:50 IST. Rational Times has not independently confirmed the details: read each report through the links below.

StatusVerified
Reported by2 news organisations
First report13 Nov, 06:31 IST
Latest report13 Nov, 15:50 IST
DeskWorld

What the reports sayEach newsroom’s own summary of its report, from its feed

China has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s first available oral GLP-1 treatment for obesity as global drug makers seek to tap the country’s massive weight-management market. China’s National…
China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.

Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.

About ChinaAsia 13 Nov 2026

The reports2 reports

Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake

Read nextThe biggest stories right now